- OUTLOOK
Obstacles and opportunities: how psychedelic medicine can rise to its challenges
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
doi: https://doi.org/10.1038/d41586-022-03440-x
This article is part of Nature Outlook: Psychedelic medicine, an editorially independent supplement produced with the financial support of third parties. About this content.
Psychedelic medicine faces the acid test
Taking the tripping out of psychedelic medicine
Hope that psychedelic drugs can erase trauma
How MDMA resensitizes the brain
The psychedelic escape from depression
Finding medical value in mescaline
Your brain on psychedelics
Psychedelic research and the real world
Psychedelic microdosing hits a rough patch in clinical trials
Research round-up: psychedelic medicine
The psychedelic remedy for chronic pain
Can psychedelic drugs uncover the secrets of consciousness?